These findings suggest that high PD-L1 expression in NSCLC tissues is an important molecular marker of disease progression and plays an important role in reflecting the level of T-cell-mediated anti-tumor immune response in the tumor microenvironment10. This evidence concerns the gene CD274 and neoplasm.